US Stock MarketDetailed Quotes
BLFE BIOLIFE SCIENCES INC
- 0.000001
- 0.0000000.00%
15min DelayTrading Nov 27 16:00 ET
3.18KMarket Cap0.00P/E (TTM)
0.000001High0.000001Low32.18KVolume0.000001Open0.000001Pre Close0.03Turnover0.05%Turnover Ratio0.00P/E (Static)3.18BShares0.00020052wk High0.00P/B70.01Float Cap0.00000152wk Low--Dividend TTM70.01MShs Float2.540000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
BIOLIFE SCIENCES INC Key Stats
Quarterly+Annual
YOY
| (Q2)May 30, 2008 | (Q1)Feb 29, 2008 | (FY)Nov 30, 2007 | (Q4)Nov 30, 2007 | (Q3)Aug 30, 2007 | (Q2)May 30, 2007 | (Q1)Feb 28, 2007 | (FY)Nov 30, 2006 | (Q4)Nov 30, 2006 | (Q3)Aug 30, 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -423.21%-107.59K | -479.76%-346.59K | -657.85%-285.42K | -194.11%-151.6K | -126.47%-258.38K | 103.77%33.29K | 131.20%91.27K | -57.54%-37.66K | 410.20%161.09K | 6,295.25%976.19K |
| Net income from continuing operations | -95.98%-842.11K | -127.51%-446.45K | -602.64%-2.05M | -445.52%-1.03M | -268.33%-392.06K | -1,258.46%-429.68K | -487.79%-196.24K | 80.67%-291.19K | 86.94%-188.46K | -41.91%-106.44K |
| Operating gains losses | ---- | ---- | 155.14%56.11K | --0 | --16.38K | --14.64K | 179.04%25.1K | -109.91%-101.76K | -99.81%1.81K | ---- |
| Depreciation and amortization | 18.73%70.9K | 33.68%75.71K | 59.47%269.47K | 154.25%95.2K | -39.42%57.92K | 347.40%59.72K | 150.73%56.64K | --168.98K | --37.44K | --95.6K |
| Other non cash items | 58.39%377.45K | 155.79%98.76K | 338.38%867.3K | 520.85%438.87K | 5.94%151.51K | 2,751.29%238.31K | -74.39%38.61K | -57.49%197.84K | ---104.28K | --143.02K |
| Change In working capital | -15.85%126.48K | -144.64%-74.61K | 5,023.27%567.75K | -17.40%342.41K | -109.72%-92.13K | 116.12%150.31K | 137.86%167.16K | -17.03%-11.53K | --414.57K | --947.58K |
| -Change in receivables | 327.57%29.36K | -112.13%-8.57K | 117.01%95.23K | 57.72%-65.38K | 146.79%102.88K | 71.26%-12.9K | 150.34%70.64K | -2,698.84%-559.77K | ---154.66K | ---219.88K |
| -Change in prepaid assets | 298.70%88.53K | -180.50%-49.15K | -31.32%-26.19K | -92.21%19.48K | 106.41%16.41K | -2,543.94%-44.55K | -9.85%-17.52K | ---19.94K | --250.14K | ---255.95K |
| -Change in payables and accrued expense | -16.17%81.41K | -349.04%-72.94K | -32.56%375.48K | -15.31%247.59K | -99.65%1.49K | 431.52%97.11K | 122.91%29.29K | --556.78K | --292.34K | --421.56K |
| -Change in other current assets | ---- | -51.96%15.06K | -42.16%26.32K | ---- | ---- | ---25.99K | 124.55%31.34K | 340.00%45.51K | ---- | ---- |
| -Change in other current liabilities | ---57.76K | --40.99K | 256.62%76.91K | ---- | ---- | ---- | ---- | -200.00%-49.11K | ---- | ---- |
| -Change in other working capital | ---- | ---- | 33.33%20K | 23.53%37.5K | -121.22%-207.55K | 114.18%136.65K | 280.07%53.41K | 175.00%15K | --30.36K | --978.28K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -423.21%-107.59K | -479.76%-346.59K | -657.85%-285.42K | -194.11%-151.6K | -126.47%-258.38K | 103.77%33.29K | 131.20%91.27K | -57.54%-37.66K | 410.20%161.09K | 6,295.25%976.19K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 102.52%39.73K | 0 | 100.38%2.49K | 109.64%37.25K | 0 | -10,428.35%-1.58M | -1,173.21%-141.19K | -3,023.76%-661.47K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---24.75K | ---39.75K | --28.38K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -8,954.93%-1.36M | --0 | ---666.47K |
| Net investment purchase and sale | ---- | ---- | --39.73K | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---196.26K | --0 | -651.75%-124.83K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 102.52%39.73K | --0 | 100.38%2.49K | 109.64%37.25K | --0 | -10,428.35%-1.58M | -1,173.21%-141.19K | -3,023.76%-661.47K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 193.71%128.46K | -851.16%-39.83K | 15.18%576.71K | 445.28%464.73K | 162.00%243.75K | -153.09%-137.08K | -99.31%5.3K | -59.25%500.69K | -111.05%-134.6K | -11,021.33%-393.17K |
| Net issuance payments of debt | 441.85%128.46K | 57.71%-39.83K | -39.76%301.62K | 420.69%431.64K | 100.44%1.75K | -114.55%-37.58K | -112.23%-94.2K | -58.57%500.69K | -111.24%-134.6K | -11,021.33%-393.17K |
| Net common stock issuance | ---- | ---- | --347.3K | --105.3K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---72.21K | ---- | ---- | ---- | --99.5K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 193.71%128.46K | -851.16%-39.83K | 15.18%576.71K | 445.28%464.73K | 162.00%243.75K | -153.09%-137.08K | -99.31%5.3K | -59.25%500.69K | -111.05%-134.6K | -11,021.33%-393.17K |
| Net cash flow | ||||||||||
| Beginning cash position | -89.38%18.06K | 450.53%404.49K | -93.82%73.47K | -51.45%91.35K | -61.18%103.5K | -86.69%170.04K | -93.82%73.47K | --1.19M | 1,697.80%188.18K | --266.63K |
| Current changes in cash | 131.36%20.87K | -500.16%-386.43K | 129.66%331.02K | 372.99%313.14K | 84.52%-12.14K | 93.42%-66.54K | 10.20%96.57K | -193.82%-1.12M | -109.73%-114.7K | ---78.45K |
| End cash Position | -62.38%38.93K | -89.38%18.06K | 450.53%404.49K | 450.53%404.49K | -51.45%91.35K | -61.18%103.5K | -86.69%170.04K | -93.82%73.47K | -93.82%73.47K | 1,697.80%188.18K |
| Free cash flow | -423.21%-107.59K | -479.76%-346.59K | -357.31%-285.42K | -211.19%-151.6K | -126.11%-258.38K | 103.72%33.29K | 131.20%91.27K | -161.08%-62.41K | 362.54%136.33K | 6,380.19%989.57K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data